Etrolizumab Down but Not Out for Ulcerative Colitis: Studies Etrolizumab Down but Not Out for Ulcerative Colitis: Studies

Etrolizumab does not appear to be effective as induction or maintenance therapy for moderately to severely active ulcerative colitis, according to results of five phase 3 trials.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news